Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Drug Alcohol Depend. 2016 Jan 6;160:112–118. doi: 10.1016/j.drugalcdep.2015.12.031

Table 1.

Participant demographic, treatment, and health characteristics (N=283)

Characteristic Valid n n %

Female 281 156 55.5

Hispanic ethnicity 282 25 8.9

Race*
 Native American 283 12 4.2
 Asian 283 4 1.4
 Native Hawaiian 283 3 1.1
 African American 283 13 4.6
 White 283 254 89.8

Education 282
 High school or less 76 27.0
 Some college or technical school 157 55.7
 College or post college 49 17.3

Currently employed 281 158 56.2

Past-year problems*
 Prescription opioids 283 173 61.1
 Heroin 283 57 20.1
 Crack/cocaine 283 27 9.5
 Marijuana 283 22 7.8
 Methamphetamine 283 17 6.0
 Alcohol 283 45 15.9
 Tobacco 283 102 36.0

Lifetime opioid use*
 Prescription opioids 282 268 95.0
 Heroin 282 131 46.5
 Both 282 123 43.6

Any intravenous drug use 280 119 42.5

Lifetime opioid treatment*
 Methadone 270 114 42.2
 Buprenorphine 272 153 56.3
 Both 269 59 21.9
 Neither 269 64 23.8

Fair or poor health 283 85 30.1

Pain*

 Experience pain daily or constantly 280 149 53.3

 Severe or very severe in past 4 weeks 283 49 17.3

 Interfered with work quite a bit or
  extremely in past 4 weeks
281 65 23.1
*

Items were not mutually exclusive and will not necessarily sum to 100%.